Drug Formulary Review 2005-09-01

Joint Commission issues alert on vincristine administration

Saying tragic errors related to vincristine administration continue to occur, the Joint Commission on Accreditation of Healthcare Organizations in Oakbrook Terrace, IL, issued a Sentinel Event Alert in July. Read More

New law legally protects adverse event information

Pharmacists should be encouraged to report medication adverse events (AEs) and their underlying causes under a new law signed by President Bush on July 29. Read More

Study: Number of adverse events involves med errors

A teaching hospital further improved its existing safety mechanisms after a study of critically ill patients found a significant number of adverse events involving medications. Read More

Research News: Study: Customizing simple regimen raises adherence

Hospital admissions related to poor medication adherence cost the United States billions of dollars a year. Two physicians recently reviewed the literature and discussed adherence to medication in the Aug. 5 issue of The New England Journal of Medicine. Read More

News Briefs

The FDA has asked Purdue Pharma LP to withdraw its pain management drug hydromorphone hydrochloride (Palladone) from the market. The agency made this request after acquiring new information about serious and potentially fatal adverse reactions that can occur when hydromorphone extended-release capsules are taken together with alcohol. Read More

Drug Formulary Review Archives

September 1, 2005

View Archived Issues

Downloads